Trending...
- The Ultimate Med Spa Growth Engine: PatientNow and Aesthetix CRM Announce Strategic Integration
- LIB Large-Scale Walk-In Test Chamber Full Process Delivery: MIL-STD-810H Chambers Enable Extreme Environment Testing
- Groundbreaking Study Explores THC Beverages as a Wellness Alternative to Alcohol
FAYETTEVILLE, Ark. - PennZone -- FAYETTEVILLE, Ark. – Lineus Medical announces the completion of a $4.579 million Series C funding round. The Series C round allowed Lineus Medical to expand its sales and clinical education team, secure international regulatory clearances, and obtain additional U.S. and international patents which positions the organization for continued growth and expansion. Since its founding in 2015, Lineus Medical has raised a total of $11.5 million, supporting the continued development and commercialization of its flagship product, SafeBreak® Vascular.
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on The PennZone
Vance Clement, Lineus Medical's CEO stated, "Our investors have seen us through the trials and tribulations of starting a medical device business, obtaining FDA De Novo clearance for a new class of product, and completing several successful clinical trials. We continue to gain customers and gain market traction. We thank our investors for their support through the pandemic and over the past three years, which has been a very difficult market to raise funds. Our investors believe, as does the Lineus Medical team, that this is only the beginning. We will continue to strive to make break-away devices the new standard of care for IV lines, and SafeBreak the preferred choice of nurses around the world.
We would also like to thank the hospitals and nurses that are our customers. Without you, we are nothing. You are the early adopters and the innovators that show your patients that you care by reducing needlesticks and IV restarts. It takes vision, guts and determination to evaluate and bring new technology into your hospital. We thank you.
More on The PennZone
With these funds, we will continue to expand our customer base, lower the manufacturing cost and price of our product, and conduct clinical research showing the value of break-away devices for all types of IV lines and patients of all ages."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
References:
1. Data on File
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on The PennZone
- MoMojo Records announces posthumous album from Kip London
- Guests Can Save 20 Percent on a Florida Keys Vacation Home Rental with KeysCaribbean's 'Last-Minute Booking Discount'
- All-Woman Trial Team Wins Major Verdict in Major Case
- Children's Hospital of Philadelphia Researchers Find Gene Therapy Shows Long-Term Benefits for Hemophilia B Patients
- Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU
Vance Clement, Lineus Medical's CEO stated, "Our investors have seen us through the trials and tribulations of starting a medical device business, obtaining FDA De Novo clearance for a new class of product, and completing several successful clinical trials. We continue to gain customers and gain market traction. We thank our investors for their support through the pandemic and over the past three years, which has been a very difficult market to raise funds. Our investors believe, as does the Lineus Medical team, that this is only the beginning. We will continue to strive to make break-away devices the new standard of care for IV lines, and SafeBreak the preferred choice of nurses around the world.
We would also like to thank the hospitals and nurses that are our customers. Without you, we are nothing. You are the early adopters and the innovators that show your patients that you care by reducing needlesticks and IV restarts. It takes vision, guts and determination to evaluate and bring new technology into your hospital. We thank you.
More on The PennZone
- Thrive Cannabis Marketplace Opens New Main Street Dispensary in Las Vegas Arts District
- ReferFriends.io Officially Launches: A New Global Hub for Sharing and Discovering Referral Codes
- Emerging Managers Podcast Launches, Highlighting New Players in Venture Capital Outperforming the Status Quo
- North American Security Launches New Website to Reflect Evolving Industry Demands and Client-Centered Solutions
- Home Run Pest & Termite Control Launches Monthly Mosquito Service to Help Wylie, Plano, and Rockwall Homeowners Reclaim Their Backyards
With these funds, we will continue to expand our customer base, lower the manufacturing cost and price of our product, and conduct clinical research showing the value of break-away devices for all types of IV lines and patients of all ages."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
References:
1. Data on File
Source: Lineus Medical
Filed Under: Health, Technology
0 Comments
Latest on The PennZone
- ServiceAgent.ai Brings 24/7 AI Call Answering to America's Home Services
- Jed the Fish, The Rapscallion of Los Angeles KROQ's Airwaves and Provocateur, Has Signed Off at 69
- Affordable Braces in Allentown Offered by Leading Orthodontic Provider
- New Website Uses A.I. To Help Readers Think All Of Your Books Into Existence
- Tredence Acquires Further Advisory, Expanding its Financial Services and Insurance Consulting Capabilities USA - English India - English
- Aries Industries Earns USA Today Top Workplaces Award, Honoring Company as Great Place to Work
- The most Googled celebrity divorces in the UK
- HR Tech Awards Program Celebrates 6th Year: Showcases Top Hiring, Talent, and HR Technologies
- Strike School Unveils Bold New Rebrand with Innovative Educational Solutions for the 2025-2026 School Year
- The World's No.1 Superstar Champions the NO FAKES Act – Secures Global Identity and Cultural Legacy
- Robinson earns fourth straight supplier award from Rolls-Royce
- PebblePad Welcomes Justin Reilly as New CEO to Drive Innovation and Growth
- Jonathan Grode Recognized with Avvo Clients' Choice Award for 13th Consecutive Year
- "Reflections of WEUSI 1965 – Present" The Intersection of Power, Art, and Wellness for Stress Awareness Month
- Blaming Patients: How Failed Treatments Fuel a $51 Billion Brain Device Industry
- Children's Hospital of Philadelphia Researchers Develop Cell Atlas to Uncover Significant Shifts in the Neuroblastoma Tumor Microenvironment
- Dentist in London Ontario the Explains Expansion of Canadian Dental Care Plan
- Unlocking the Secrets of Mystery and Magic:
- Nevada Supreme Court Faces Pivotal Decision in Probate Appeal Involving Alleged Judicial Misconduct and Fiduciary Fraud
- Revolutionary Partnership Bridging AI/Youth Sports/Business